Truking Technology Net Margin
The Net Profit Margin of Truking Technology (300358.SZ) as of Aug 1, 2026 is -7.76 %. In the previous year, Net Profit Margin was 4.63 % — a change of -267.83% (lower).
Get this data via API
Financial Data API
Net Margin
-7.76 %
YoY
-267.83%
Last updated:
Net Profit Margin of Truking Technology is 2026 -7.76 % . Net Profit Margin of Truking Technology was 2025 4.63 % . It decreases by -267.83% lower compared to the previous year.
For Truking Technology, the net margin of -7.8% is down versus 5.6% a few years ago.
Access this data via the Eulerpool API
Truking Technology Stock analysis
What does Truking Technology do? Truking Technology Ltd is a leading company in the Chinese pharmaceutical industry based in Wenzhou. It was founded in 1997 and started as a small company manufacturing pumps for the pharmaceutical industry. Truking is now a global company with subsidiaries in various countries, offering a wide range of products and solutions for pharmaceutical manufacturers worldwide.
The business model of Truking is focused on the needs of the pharmaceutical industry. The company provides a wide range of solutions for the production of pharmaceutical products such as liquids, powders, and tablets. The goal of the company is to optimize its customers' processes and reduce costs by offering innovative equipment and advanced technology.
Truking has three main divisions: pharmaceutical equipment, medical technology, and laboratory technology. In pharmaceutical equipment, the company produces a wide range of pumps, valves, tanks, agitators, and filters. These products are essential for the production of pharmaceutical preparations and formulations. Truking's medical technology division offers solutions for clinical diagnostics, including medical imaging and diagnostic devices. The laboratory technology division, on the other hand, produces equipment for research purposes in the pharmaceutical industry, including laboratory reactors, chromatography systems, and automation solutions.
Truking has earned a reputation for high quality and reliability in the industry. The company manufactures products according to international standards such as ISO, FDA, and GMP. Truking's production facilities are equipped with state-of-the-art facilities and technologies to ensure that the products meet the highest standards.
Truking's product range includes a variety of pumps that meet different customer requirements. The peristaltic pump is very popular due to its high dosing accuracy. It is ideal for sensitive media and for uniform dosing of liquids and powders. The centrifugal pump, on the other hand, is well-suited for the conveyance of corrosive and abrasive fluids, as it is robust and durable. The rotary vane pump, hose pump, and diaphragm pump are also part of the product range, as well as agitators, filters, valves, and specialty equipment.
Truking Technology Ltd has become one of the leading companies in the pharmaceutical equipment industry. With its wide range of products and solutions for pharmaceutical production, the company has a firm position in the global market. It is committed to meeting its customers' requirements and supporting them in optimizing their processes to gain a competitive advantage in the market. Truking Technology is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Truking Technology stock
Net Profit Margin of Truking Technology is -7.76 % in 2026.
Access this data via the Eulerpool API
Margins — Truking Technology
All Key Metrics — Truking Technology
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth